跳至主要内容
临床试验/IRCT20221002056073N1
IRCT20221002056073N1招募中3 期

Comparing of Gabapentin and Cinnarizine Effect on Tinnitus in Patients with Sensorineural Hearing Loss

Oroumia University of Medical Sciences0 个研究点目标入组 114 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • The patient has continuous tinnitus without pulsation for at least one year.
  • Having sensorineural hearing loss
  • Based on the Tinnitus Handicap Inventory (THI), the patient must have scored 38 or higher.

排除标准

  • Having active Meniere's Disease
  • Having Kidney Dysfunction
  • Being pregnant or breastfeeding
  • Having any of the following: Glaucoma, Urinary Retention, Prostate Hypertrophy, Epilepsy and Liver Disease
  • Having a health condition that prohibits the use of Gabapentin for the patient or other Contraindications

研究者

发起方
Oroumia University of Medical Sciences

相似试验

Comparing of Gabapentin and Cinnarizine Effect on... | 临床试验